Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE.

iScience. 2019 Jul 24. pii: S2589-0042(19)30228-7. doi: 10.1016/j.isci.2019.07.003. [Epub ahead of print]

2.

A Role for IFITM Proteins in Restriction of Mycobacterium tuberculosis Infection.

Ranjbar S, Haridas V, Jasenosky LD, Falvo JV, Goldfeld AE.

Cell Rep. 2015 Nov 3;13(5):874-83. doi: 10.1016/j.celrep.2015.09.048. Epub 2015 Oct 22.

3.

T cells and adaptive immunity to Mycobacterium tuberculosis in humans.

Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE.

Immunol Rev. 2015 Mar;264(1):74-87. doi: 10.1111/imr.12274. Review.

PMID:
25703553
4.

TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.

Haridas V, Pean P, Jasenosky LD, Madec Y, Laureillard D, Sok T, Sath S, Borand L, Marcy O, Chan S, Tsitsikov E, Delfraissy JF, Blanc FX, Goldfeld AE; CAPRI-T (ANRS 12164) Study Team.

AIDS. 2015 Jan 28;29(3):263-73. doi: 10.1097/QAD.0000000000000546.

5.

A distal locus element mediates IFN-γ priming of lipopolysaccharide-stimulated TNF gene expression.

Chow NA, Jasenosky LD, Goldfeld AE.

Cell Rep. 2014 Dec 11;9(5):1718-1728. doi: 10.1016/j.celrep.2014.11.011. Epub 2014 Dec 4.

6.

Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation.

Falvo JV, Jasenosky LD, Kruidenier L, Goldfeld AE.

Adv Immunol. 2013;118:37-128. doi: 10.1016/B978-0-12-407708-9.00002-9. Review.

7.

Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway.

Ranjbar S, Jasenosky LD, Chow N, Goldfeld AE.

PLoS Pathog. 2012;8(4):e1002620. doi: 10.1371/journal.ppat.1002620. Epub 2012 Apr 5.

8.

The use of HaloTag-based technology in flow and laser scanning cytometry analysis of live and fixed cells.

Kovalenko EI, Ranjbar S, Jasenosky LD, Goldfeld AE, Vorobjev IA, Barteneva NS.

BMC Res Notes. 2011 Sep 9;4:340. doi: 10.1186/1756-0500-4-340.

9.

Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat.

Falvo JV, Ranjbar S, Jasenosky LD, Goldfeld AE.

Am J Respir Cell Mol Biol. 2011 Dec;45(6):1116-24. doi: 10.1165/rcmb.2011-0186TR. Epub 2011 Aug 18. Review.

10.

ALIX/AIP1 is required for NP incorporation into Mopeia virus Z-induced virus-like particles.

Shtanko O, Watanabe S, Jasenosky LD, Watanabe T, Kawaoka Y.

J Virol. 2011 Apr;85(7):3631-41. doi: 10.1128/JVI.01984-10. Epub 2011 Jan 19.

11.

Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.

Jasenosky LD, Neumann G, Kawaoka Y.

Antimicrob Agents Chemother. 2010 Jul;54(7):3007-10. doi: 10.1128/AAC.00138-10. Epub 2010 Apr 26.

12.

Ebola virus VP40 late domains are not essential for viral replication in cell culture.

Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, Watanabe S, Kim JH, Feldmann H, Kawaoka Y.

J Virol. 2005 Aug;79(16):10300-7.

13.

Filovirus budding.

Jasenosky LD, Kawaoka Y.

Virus Res. 2004 Dec;106(2):181-8. Review.

PMID:
15567496
14.

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y.

J Virol. 2004 Jan;78(2):999-1005.

15.

Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Jasenosky LD, Neumann G, Lukashevich I, Kawaoka Y.

J Virol. 2001 Jun;75(11):5205-14.

Supplemental Content

Loading ...
Support Center